Coherus to Report Third Quarter 2024 Financial Results on November 6, 2024
Rhea-AI Summary
Coherus BioSciences (NASDAQ: CHRS) has announced it will release its third quarter 2024 financial results after market close on Wednesday, November 6, 2024. The company's management will host a conference call and webcast at 5:00 p.m. ET on the same day to discuss the results and provide a business update. Investors can access the conference call through pre-registration and join the webcast through the company's investor relations website. The financial results press release and related materials will be available before the call on the Coherus investor website.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, CHRS declined 0.65%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
REDWOOD CITY, Calif., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus,” NASDAQ: CHRS) today announced that its third quarter 2024 financial results will be released after market close on Wednesday, November 6, 2024. Starting at 5:00 p.m. ET on November 6, 2024, Coherus’ management team will host a conference call and webcast to discuss financial results and provide a general business update.
A webcast replay will be available on https://investors.coherus.com following the conclusion of the live conference call.
Conference Call Information
When: Wednesday, November 6, 2024, starting at 5:00 p.m. Eastern Time
To access the conference call, please pre-register through the following link to receive dial-in information and a personal PIN to access the live call: https://register.vevent.com/register/BI6dfb4eba6e9a4322a716df863233a53f
Webcast: https://edge.media-server.com/mmc/p/fgk872yp
The press release with the third quarter 2024 financial results and related materials will be available at https://investors.coherus.com before the start of the conference call.
A live and archived webcast will be available on the “Investors” section of the Coherus website at https://investors.coherus.com/events-presentations.
Please dial in 15 minutes early to ensure a timely connection to the call.
Disclosure Information
Coherus uses the https://investors.coherus.com website to disclose material non-public information and comply with its disclosure obligations under Regulation FD.
Coherus Contact Information
Investors:
Jodi Sievers, Vice President, Investor Relations and Corporate Communications
IR@coherus.com
FAQ
When will Coherus BioSciences (CHRS) release Q3 2024 earnings?
What time is the Coherus BioSciences (CHRS) Q3 2024 earnings call?
How can investors access the Coherus BioSciences (CHRS) Q3 2024 earnings call?
